• FK866 (APO866): Precision NAMPT Inhibition in Cancer Researc

  2026-05-27

  FK866 (APO866) is redefining cancer biology workflows by selectively targeting NAD biosynthesis with nanomolar potency. Recent reference studies demonstrate how combining FK866 with PARP inhibitors leverages metabolic vulnerabilities in RAS/PI3K-mutant ovarian and hematologic cancers, unlocking new avenues for selective cytotoxicity and resistance management.

• Humanized Gs-Coupled DREADD Enables Safer Neural Circuit Mod

  2026-05-26

  This study introduces a fully humanized Gs-coupled DREADD (hM3Ds), addressing immunogenicity concerns and demonstrating functional equivalence to rodent models. The innovation expands the translational potential of chemogenetic neuromodulation, with clear implications for both research and clinical applications.

• Clarithromycin as a CYP3A Inhibitor: Advanced Workflows & So

  2026-05-26

  Clarithromycin stands out as a gold-standard CYP3A inhibitor, enabling high-fidelity drug-drug interaction and pharmacokinetic studies—especially in scenarios involving statin and cardiovascular drug metabolism. This guide distills best practices, troubleshooting tips, and the latest evidence for optimizing experimental workflows using APExBIO's Clarithromycin.

• Trelagliptin Succinate: Mechanistic Insights for Insulin Res

  2026-05-25

  Explore how Trelagliptin succinate, a selective DPP-4 inhibitor, improves insulin resistance through nuanced pathway modulation. This article offers advanced protocol guidance and unique mechanistic perspectives for type 2 diabetes research.

• Hypoxia, Immunometabolism, and Redox Regulation in Tumors

  2026-05-25

  This review synthesizes current understanding of how hypoxia and immune metabolic reprogramming shape the tumor microenvironment, driving immunosuppression and tumor progression. By dissecting mechanisms linking oxygen deprivation, metabolic shifts, and immune cell fate, the study outlines both challenges and therapeutic opportunities in targeting tumor immunometabolism.

• mCherry mRNA: Optimizing Red Fluorescent Reporter Workflows

  2026-05-24

  Harness the power of EZ Cap™ mCherry mRNA for robust, immune-evasive fluorescent protein expression in advanced cell assays. Discover practical protocols, troubleshooting strategies, and workflow enhancements that set this reporter gene mRNA apart for translational and imaging applications.

• BMS-777607: Selective c-Met Inhibitor for MET Pathway Resear

  2026-05-23

  BMS-777607 is a potent ATP-competitive c-Met inhibitor with nanomolar selectivity for MET kinase family members. It enables precise modulation of MET signaling in cancer and stem cell models, offering robust evidence for apoptosis and metastasis suppression.

• N1-Methyl-Pseudouridine-5'-Triphosphate: Reliable Modified N

  2026-05-22

  This article presents scenario-driven, evidence-based strategies for addressing core challenges in cell viability, proliferation, and cytotoxicity assays using N1-Methyl-Pseudouridine-5'-Triphosphate (SKU B8049). Leveraging validated literature and best practices, it highlights how the APExBIO product enhances RNA stability, translational efficiency, and reproducibility in demanding experimental contexts.

• Erlotinib (NSC 718781) in Translational Oncology: Mechanisti

  2026-05-22

  This article examines the evolving landscape of EGFR-targeted research, centering on Erlotinib (NSC 718781) as a mechanistic probe and translational lever in cancer biology. Integrating recent discoveries on SCUBE3-driven oncogenic signaling, it offers protocol recommendations, contextualizes competitive advances, and provides strategic guidance for researchers navigating resistance and immunosuppression in cancer models.

• Protease Inhibitor Cocktail Boosts Protein Stability in Lipo

  2026-05-21

  Unlock high-fidelity protein extraction in lipid droplet research with the Protease Inhibitor Cocktail (100X H₂O, EDTA Plus) from APExBIO. This ready-to-use mixture streamlines workflows, ensuring reliable protein stability even during stress-triggered lipolysis studies.

• Machine Learning Identifies New Senolytics for Cancer Resear

  2026-05-21

  The referenced study presents a machine learning-driven approach to senolytic discovery, enabling identification of three novel compounds that selectively eliminate senescent cells. This innovation reduces drug screening costs and supports the development of targeted therapies for conditions including cancer and age-related diseases.

• Afatinib (BIBW 2992) in Advanced Tumor Assembloid Research

  2026-05-20

  Afatinib empowers high-fidelity cancer research by irreversibly inhibiting EGFR, HER2, and HER4 signaling in complex assembloid models. This approach enables deeper insights into drug resistance and personalized therapy optimization, outperforming traditional monoculture assays.

• EdU Imaging Kits (Cy3): Precision S-Phase DNA Synthesis Dete

  2026-05-20

  EdU Imaging Kits (Cy3) deliver unmatched sensitivity for tracking S-phase DNA synthesis in proliferating cells, leveraging click chemistry to overcome the limitations of BrdU assays. Explore advanced workflows, experimental insights, and troubleshooting strategies that empower cancer and genotoxicity research.

• BMS 599626 Dihydrochloride: EGFR and ErbB2 Inhibitor in Onco

  2026-05-19

  BMS 599626 dihydrochloride stands out as a robust and highly selective EGFR and ErbB2 inhibitor, empowering translational researchers to dissect oncogenic signaling with precision. This article details real-world workflows, troubleshooting best practices, and the strategic integration of this compound in advanced cancer studies, bridging data-driven insights with practical lab guidance.

• Mild ER Stress Activation Enhances Cadmium Resistance in C.

  2026-05-19

  This study demonstrates that mild activation of the endoplasmic reticulum unfolded protein response (UPRER) increases cadmium resistance in Caenorhabditis elegans, highlighting a nuanced role for protein homeostasis pathways in environmental toxicology. The findings provide mechanistic insight into ER stress adaptation and support research into molecular modulators of stress resilience.

8080 records 15/539 page Previous Next First page 上5页 1112131415 下5页 Last page